Biofrontera(BFRI) - 2023 Q3 - Quarterly Report
(Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 For the quarterly period ended September 30, 2023 Commission file number 001-40943 | --- | --- | --- | |------------------------------------------------------|---------------------|-------------------------------------------------------| | Title of each class | Trading Symbol(s) | Name of each exchange on which registered | | Common stock, par value $0.001 per share | BFRI | The Nasdaq Stock Market LLC | | Preferred Stock Pur ...